Table 3.
Diagnosed COVID-positive patients (RT-PCR/Radiological). ERCP endoscopic retrograde cholangiopancreatography, EUS endoscopic ultrasound, NJ nasojejunal. EVL endoscopic variceal ligation, NBT nasobiliary tube, PEG percutaneous endoscopic gastrostomy, HPB hepato-pancreato-biliary, WON walled-off necrosis, SEMS self-expanding metal stent, RFA radiofrequency ablation, GI gastrointestinal, COVID-19 RT-PCR corona virus disease-19 reverse transcriptase polymerase chain reaction, CO-RADS corona virus disease - 19 reporting and data system
| Indications | Procedures | N |
|---|---|---|
| COVID-19 RT-PCR positive | ||
| Evidence of GI bleed | EVL (4), Dieulafoy’s lesion hemoclipping (1),hemorrhoidal banding (1) | 6 |
| Biliary sepsis | ERCP with plastic stent (3)/SEMS (1),EUS for biliary stone (2) | 5 |
| Suspected HPB cancer | EUS with biopsy | 1 |
| Necrotizing pancreatitis with WON | EUS guided drainage | 1 |
| Nutrition | NJ placement | 1 |
| Insulinoma (pain abdomen) | EUS RFA | 1 |
| Colonic SEMS reposition | Colonoscopy | 1 |
| Total | 16 (0.46%) | |
| CO-RADS 4/5 (Subheading as COVID-19 positve) | ||
| Evidence of GI bleed | EVL (4), hemoclipping (1), hemorrhoidalbanding (1) | 6 |
| Foreign body removal | Endoscopy | 1 |
| Biliary sepsis | ERCP with stenting (plastic/SEMS) | 4 |
| Nutrition | NJ placement | 3 |
| Severe pancreatitis with symptomatic fluid collection | EUS diagnostic | 2 |
| Suspected HPB malignancy | EUS biopsy | 2 |
| Total | 18 (0.52%) | |